Ashley Rosko, MD
Practitioners in the field of multiple myeloma are seeking to answer several questions regarding the treatment of elderly patients, a population that, due to comorbidities, may have difficulty tolerating some of the currently available therapies.
on Hematologic Malignancies. In an interview, she shared insight on some of these available therapies, others under investigation, and supportive care methods being utilized for this patient population.
OncLive: You lectured on elderly patients with multiple myeloma. What is important to know about this subset?
The bulk of therapy for multiple myeloma is nontransplant based. Not to say that transplant isn’t indicated for older adults because it is, but it is underutilized. This presentation focused on why older adults have inferior survival, the approach in terms of treatment when it comes to older adults with myeloma, and some of the supportive care methods that we’re able to better utilize for them.
... to read the full story